This Article Full Text Full Text (PDF) Erratum (v24,p2133) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gerber, D. E. Articles by Streiff, M. B. Search for Related Content PubMed PubMed Citation Articles by Gerber, D. E. Articles by Streiff, M. B. Social Bookmarking                            What's this?

Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors

From the Departments of Oncology, Medicine, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD

Address reprint requests to Michael B. Streiff, MD, Division of Hematology, The Johns Hopkins University School of Medicine, 1830 E Monument St, Suite 7300, Baltimore, MD 21205; e-mail: mstreif{at}jhmi.edu

Venous thromboembolism occurs commonly throughout the clinical course of patients with brain tumors. A number of hemostatic and clinical factors contribute to this hypercoagulable state. Concern over the possibility of intracranial bleeding has limited the use of anticoagulation in this population. However, mechanical approaches such as vena cava filters have high complication and treatment failure rates in patients with intracranial malignancies. In addition, the available data suggest that anticoagulation can be used safely and effectively in most of these patients. Patients with thrombocytopenia, recent neurosurgery, and tumor types prone to bleeding require special consideration. When intracranial hemorrhage does occur, it is often due to overanticoagulation, requiring prompt anticoagulation reversal and neurosurgical consultation.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. F. Barginear, M. Lesser, M. L. Akerman, M. Strakhan, I. Shapira, T. Bradley, and D. R. Budman Need for Inferior Vena Cava Filters in Cancer Patients: A Surrogate Marker for Poor Outcome Clinical and Applied Thrombosis/Hemostasis, June 1, 2009; 15(3): 263 - 269. [Abstract] [PDF]

				P. Y. Wen and S. Kesari Malignant Gliomas in Adults N. Engl. J. Med., July 31, 2008; 359(5): 492 - 507. [Full Text] [PDF]

				A. A. Khorana, C. W. Francis, A. Falanga, and G. H. Lyman In Reply J. Clin. Oncol., April 10, 2008; 26(11): 1906 - 1907. [Full Text] [PDF]

				A. Falanga, A. Y. Y. Lee, M. B. Streiff, and G. H. Lyman Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer ASCO Educational Book, January 1, 2008; 2008(1): 258 - 268. [Abstract] [Full Text] [PDF]

				R. Simanek, R. Vormittag, M. Hassler, K. Roessler, M. Schwarz, C. Zielinski, I. Pabinger, and C. Marosi Venous thromboembolism and survival in patients with high-grade glioma Neuro-oncol, April 1, 2007; 9(2): 89 - 95. [Abstract] [Full Text] [PDF]

				T. S. Lawrence, J. C. Buckner, and F. F. Lang CNS Malignancies: At Last, Real Progress J. Clin. Oncol., March 10, 2006; 24(8): 1225 - 1227. [Full Text] [PDF]